High Tide stock rating resumed at Buy by Canaccord with C$7.25 target

Published 09/24/2025, 10:53 AM
High Tide stock rating resumed at Buy by Canaccord with C$7.25 target

Investing.com - Canaccord Genuity has resumed coverage of High Tide Inc. (NASDAQ:HITI) with a Buy rating and a price target of C$7.25, according to a research note released Wednesday. The stock has shown remarkable momentum, delivering a 78% return over the past year and 65% over the last six months, according to InvestingPro data.

The cannabis retailer operates 207 Canna Cabana stores across Canada and has built a loyalty program with more than 2.15 million members, creating what Canaccord describes as "superior unit economics and recurring traffic" in competitive markets. With annual revenue of $410 million and an 11% year-over-year growth rate, High Tide maintains a "GREAT" financial health score on InvestingPro.

Canaccord analyst Luke Hannan highlighted High Tide’s retail-first business model as a key strength, noting the company’s strategy has positioned it well within Canada’s cannabis retail landscape.

The firm also pointed to potential margin expansion opportunities through High Tide’s white-label brands, alongside international growth catalysts including the company’s Remexian operations in Germany.

Canaccord characterized High Tide as offering a "compelling blend of defensive cash flow and global optionality," with additional upside potential from possible cannabis rescheduling in the United States.

In other recent news, High Tide Inc. announced its Q3 2025 earnings, showcasing a notable increase in revenue and a positive earnings per share (EPS) outcome. The company reported a revenue of $149.7 million, significantly surpassing the forecasted $106.52 million by 40.53%. Additionally, High Tide Inc.’s EPS was $0.01, exceeding expectations of a $-0.01 loss. This performance highlights the company’s strong financial results for the quarter. The earnings report has drawn attention from investors due to its impressive figures. These recent developments are critical for stakeholders evaluating the company’s financial health.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.